Keywords: modest, rise, sales, novartis, lower, expected, posted
Modest Rise In Sales At Novartis Lower Than Expected
Article | 22 April 1998
Novartis has posted a modest 3% sales increase in local currencies forthe first three months of 1998 to 8.2 billion Swiss francs ($5.48 billion) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
